Armen S. Manoukian
Ontario Institute for Cancer Research
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Armen S. Manoukian.
Nature | 2002
Michael A. Crackower; Gavin Y. Oudit; Chana Yagil; Ivona Kozieradzki; Sam E. Scanga; Antonio J. Oliveira-dos-Santos; Joan da Costa; Liyong Zhang; York Pei; James W. Scholey; Carlos M. Ferrario; Armen S. Manoukian; Mark C. Chappell; Peter H. Backx; Yoram Yagil; Josef M. Penninger
Cardiovascular diseases are predicted to be the most common cause of death worldwide by 2020. Here we show that angiotensin-converting enzyme 2 (ace2) maps to a defined quantitative trait locus (QTL) on the X chromosome in three different rat models of hypertension. In all hypertensive rat strains, ACE2 messenger RNA and protein expression were markedly reduced, suggesting that ace2 is a candidate gene for this QTL. Targeted disruption of ACE2 in mice results in a severe cardiac contractility defect, increased angiotensin II levels, and upregulation of hypoxia-induced genes in the heart. Genetic ablation of ACE on an ACE2 mutant background completely rescues the cardiac phenotype. But disruption of ACER, a Drosophila ACE2 homologue, results in a severe defect of heart morphogenesis. These genetic data for ACE2 show that it is an essential regulator of heart function in vivo.
Cell | 2001
Sebastian Martinek; Susan Inonog; Armen S. Manoukian; Michael W. Young
Tissue-specific overexpression of the glycogen synthase kinase-3 (GSK-3) ortholog shaggy (sgg) shortens the period of the Drosophila circadian locomotor activity cycle. The short period phenotype was attributed to premature nuclear translocation of the PERIOD/TIMELESS heterodimer. Reducing SGG/GSK-3 activity lengthens period, demonstrating an intrinsic role for the kinase in circadian rhythmicity. Lowered sgg activity decreased TIMELESS phosphorylation, and it was found that GSK-3 beta specifically phosphorylates TIMELESS in vitro. Overexpression of sgg in vivo converts hypophosphorylated TIMELESS to a hyperphosphorylated protein whose electrophoretic mobility, and light and phosphatase sensitivity, are indistinguishable from the rhythmically produced hyperphosphorylated TIMELESS of wild-type flies. Our results indicate a role for SGG/GSK-3 in TIMELESS phosphorylation and in the regulated nuclear translocation of the PERIOD/TIMELESS heterodimer.
Cell | 2010
J. Andrew Pospisilik; Daniel Schramek; Harald Schnidar; Shane J. Cronin; Nadine T. Nehme; Xiaoyun Zhang; Claude Knauf; Patrice D. Cani; Karin Aumayr; Jelena Todoric; Martina Bayer; Arvand Haschemi; Vijitha Puviindran; Krisztina Tar; Michael Orthofer; G. Gregory Neely; Georg Dietzl; Armen S. Manoukian; Martin Funovics; Gerhard Prager; Oswald Wagner; Dominique Ferrandon; Fritz Aberger; Chi-chung Hui; Harald Esterbauer; Josef M. Penninger
Over 1 billion people are estimated to be overweight, placing them at risk for diabetes, cardiovascular disease, and cancer. We performed a systems-level genetic dissection of adiposity regulation using genome-wide RNAi screening in adult Drosophila. As a follow-up, the resulting approximately 500 candidate obesity genes were functionally classified using muscle-, oenocyte-, fat-body-, and neuronal-specific knockdown in vivo and revealed hedgehog signaling as the top-scoring fat-body-specific pathway. To extrapolate these findings into mammals, we generated fat-specific hedgehog-activation mutant mice. Intriguingly, these mice displayed near total loss of white, but not brown, fat compartments. Mechanistically, activation of hedgehog signaling irreversibly blocked differentiation of white adipocytes through direct, coordinate modulation of early adipogenic factors. These findings identify a role for hedgehog signaling in white/brown adipocyte determination and link in vivo RNAi-based scanning of the Drosophila genome to regulation of adipocyte cell fate in mammals.
Methods in Cell Biology | 1994
Andrea H. Brand; Armen S. Manoukian; Norbert Perrimon
Publisher Summary There are now several different methods for ectopic expression in Drosophila , each with its merits and its limitations. The first technique is to drive expression of a gene using the transcriptional regulatory sequences from a defined promoter. Tissue-specific promoters allow transcription to be restricted to a defined subset of cells. The second method is to drive expression of a gene from a heat-shock promoter. A gene can then be turned on at a specific point in development by heat shocking the transgenic animal. A more recent inducible technique for ectopic expression relies on site-specific recombination catalyzed by the flp recombinase from Saccharomyces cereuisiae . flp can promote recombination between two flp recombination targets, or FRTs. Advantages of the flp /FRT system are that it is inducible and expression can be activated in any cell in the organism, although dividing cells may be favored. A disadvantage of the method is that, because the clones are generated randomly, ectopic expression varies from animal to animal. The chapter describes protocols for two of the techniques that are currently used to conduct ectopic expression experiments: the heat-shock method and the GAL4 system.
Oncogene | 2000
Sam Scanga; Laurent Ruel; Richard Binari; Brian Snow; Vuk Stambolic; Denis Bouchard; Malte Peters; Batista Calvieri; Tak W. Mak; James R. Woodgett; Armen S. Manoukian
Akt (or PKB) is an oncogene involved in the regulation of cell survival. Akt is regulated by phosphatidylinositol 3-OH kinase (PI3′K) signaling and has shown to be hyperactivated through the loss of the PTEN tumor suppressor. In Drosophila, insulin signaling as studied using the Drosophila IRS-4 homolog (Chico) has been shown to be a crucial regulator of cell size. We have studied Drosophila Akt (Dakt1) and have shown that it is also involved in the regulation of cell size. Furthermore we have performed genetic epistasis tests to demonstrate that in Drosophila, PI3′K, PTEN and Akt comprise a signaling cassette that is utilized during multiple stages of development. In addition, we show that this signaling cassette is also involved in the regulation of cell survival during embryogenesis. This study therefore establishes the evolutionary conservation of this signaling pathway in Drosophila.
Current Biology | 1998
Brian E. Staveley; Laurent Ruel; Jing Jin; Vuk Stambolic; Fabrizio Mastronardi; Pascal Heitzler; James R. Woodgett; Armen S. Manoukian
The decision between survival and death is an important aspect of cellular regulation during development and malignancy. Central to this regulation is the process of apoptosis, which is conserved in multicellular organisms [1]. A variety of signalling cascades have been implicated in modulation of apoptosis, including the phosphatidylinositol (Pl) 3-kinase pathway. Activation of Pl 3-kinase is protective, and inhibition of this lipid kinase enhances cell death under several conditions including deregulated expression of c-Myc, neurotrophin withdrawal and anoikis [2-7]. Recently, the protective effects of Pl 3-kinase have been linked to its activation of the pleckstrin homology (PH)-domain-containing protein kinase B (PKB or AKT) [8]. PKB/AKT was identified from an oncogene, v-akt, found in a rodent T-cell lymphoma [9]. To initiate a genetic analysis of PKB, we have isolated and characterized a Drosophila PKB/AKT mutant (termed Dakt1) that exhibits ectopic apoptosis during embryogenesis as judged by induction of membrane blebbing, DNA fragmentation and macrophage infiltration. Apoptosis caused by loss of Dakt function is rescued by caspase suppression but is distinct from the previously described reaper/grim/hid functions. These data implicate Dakt1 as a cell survival gene in Drosophila, consistent with cell protection studies in mammals.
Journal of Circadian Rhythms | 2007
Sevag A Kaladchibachi; Norman Anthopoulos; James R. Woodgett; Armen S. Manoukian
BACKGROUND Bipolar disorder (BPD) is a widespread condition characterized by recurring states of mania and depression. Lithium, a direct inhibitor of glycogen synthase kinase 3 (GSK3) activity, and a mainstay in BPD therapeutics, has been proposed to target GSK3 as a mechanism of mood stabilization. In addition to mood imbalances, patients with BPD often suffer from circadian disturbances. GSK3, an essential kinase with widespread roles in development, cell survival, and metabolism has been demonstrated to be an essential component of the Drosophila circadian clock. We sought to investigate the role of GSK3 in the mammalian clock mechanism, as a possible mediator of lithiums therapeutic effects. METHODS GSK3 activity was decreased in mouse embryonic fibroblasts (MEFs) genetically and pharmacologically, and changes in the cyclical expression of core clock genes--mPer2 in particular--were examined. RESULTS We demonstrate that genetic depletion of GSK3 in synchronized oscillating MEFs results in a significant delay in the periodicity of the endogenous clock mechanism, particularly in the cycling period of mPer2. Furthermore, we demonstrate that pharmacological inhibition of GSK3 activity by kenpaullone, a known antagonist of GSK3 activity, as well as by lithium, a direct inhibitor of GSK3 and the most common treatment for BPD, induces a phase delay in mPer2 transcription that resembles the effect observed with GSK3 knockdown. CONCLUSION These results confirm GSK3 as a plausible target of lithium action in BPD therapeutics, and suggest the circadian clock mechanism as a significant modulator of lithiums clinical benefits.
Journal of Biological Chemistry | 1999
Laurent Ruel; Vuk Stambolic; Adnan Ali; Armen S. Manoukian; James R. Woodgett
The protein-serine kinase ShaggyZeste-white3 (SggZw3) is theDrosophila homolog of mammalian glycogen synthase kinase-3 and has been genetically implicated in signal transduction pathways necessary for the establishment of patterning. SggZw3 is a putative component of the Wingless (Wg) pathway, and epistasis analyses suggest that SggZw3 function is repressed by Wg signaling. Here, we have investigated the biochemical consequences of Wg signaling with respect to the SggZw3 protein kinase in two types ofDrosophila cell lines and in embryos. Our results demonstrate that SggZw3 activity is inhibited following exposure of cells to Wg protein and by expression of downstream components of Wg signaling, Drosophila frizzled 2 anddishevelled. Wg-dependent inactivation of SggZw3 is accompanied by serine phosphorylation. We also show that the level of SggZw3 activity regulates the stability of Armadillo protein and modulates the level of phosphorylation of D-Axin and Armadillo. Together, these results provide direct biochemical evidence in support of the genetic model of Wg signaling and provide a model for dissecting the molecular interactions between the signaling proteins.
Proceedings of the National Academy of Sciences of the United States of America | 2002
Malte Peters; Carmela DeLuca; Atsushi Hirao; Vuk Stambolic; Julia Potter; Lily Zhou; Jennifer Liepa; Bryan E. Snow; Sudha Arya; Jorge A. Wong; Denis Bouchard; Richard Binari; Armen S. Manoukian; Tak W. Mak
The tumor suppressor function of p53 has been attributed to its ability to regulate apoptosis and the cell cycle. In mammals, DNA damage, aberrant growth signals, chemotherapeutic agents, and UV irradiation activate p53, a process that is regulated by several posttranslational modifications. In Drosophila melanogaster, however, the regulation modes of p53 are still unknown. Overexpression of D. melanogaster p53 (Dmp53) in the eye induced apoptosis, resulting in a small eye phenotype. This phenotype was markedly enhanced by coexpression with D. melanogaster Chk2 (DmChk2) and was almost fully rescued by coexpression with a dominant-negative (DN), kinase-dead form of DmChk2. DN DmChk2 also inhibited Dmp53-mediated apoptosis in response to DNA damage, whereas overexpression of Grapes (Grp), the Drosophila Chk1-homolog, and its DN mutant had no effect on Dmp53-induced phenotypes. DmChk2 also activated the Dmp53 transactivation activity in cultured cells. Mutagenesis of Dmp53 amino terminal Ser residues revealed that Ser-4 is critical for its responsiveness toward DmChk2. DmChk2 activates the apoptotic activity of Dmp53 and Ser-4 is required for this effect. Contrary to results in mammals, Grapes, the Drosophila Chk1-homolog, is not involved in regulating Dmp53. Chk2 may be the ancestral regulator of p53 function.
Neuroreport | 2000
Fabrizio Mastronardi; Jim Dimitroulakos; Suzanne Kamel-Reid; Armen S. Manoukian
We demonstrate co-localization of the Patched 1 (Ptcl) receptor and its ligand sonic hedgehog (Shh) in lysosomes suggests an intracellular sorting mechanism for this receptor and its ligand. Treatment of murine brain primary cultures and a human teratoma cell line with the N-terminal activated form of Shh (ShhNT), a Ptc1-Shh complex was observed in lysosomes. Consistent with this interaction, Western immuno-blot analysis revealed intracellular localization of native Ptc1 and ShhNT. Examination of the topological model of the Ptc1 receptor revealed a number of Yxxϵ lysosomal targeting sequences consistent with our observations for Ptc1 sorting.